Company / Free Cash Flow
Bio-Rad Laboratories Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$374.6M
FY2025
5-year range
$81.6M / $535.7M
FY2021-FY2025
Trend
+29.4%
vs FY2024
Sector context
#50 of 151
Health Care
What the data says
At $375M, Bio-Rad Laboratories's free cash flow ranks #50 of 151 in the Health Care sector. Free Cash Flow has increased for 3 consecutive years, from $82M in FY2022 to $375M in FY2025.
Based on SEC 10-K filings.
$375M in FY2025 with a 5-year CAGR of +19.2%.
Improved from $218M to $375M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +66.2%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
#50 of 151 in Health CareTop 33% of 151This company $374.6M Sector average $779.8M
▼
-52.0% below sector average
Key checks
Key Insights
- Bio-Rad Laboratories's free cash flow has grown for 3 consecutive years.
- 5-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, free cash flow increased 29.4% year-over-year.
- Ranks #50 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $374.6M | +29.4% |
| FY2024 | $289.6M | +32.7% |
| FY2023 | $218.2M | +167.4% |
| FY2022 | $81.6M | -84.8% |
| FY2021 | $535.7M | +244.1% |
| FY2020 | $155.7M | -56.7% |
| FY2019 | $359.4M | +381.5% |
| FY2018 | $74.6M | +0.6% |
| FY2017 | $74.2M | -51.3% |
| FY2016 | $152.3M | +105.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026